PASSAGE BIO INC (PASG)

US7027121000 - Common Stock

0.829  0 (-0.12%)

After market: 0.8149 -0.01 (-1.7%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
69.34M103.00M138.39M185.73M112.90M
Research and Development
42.78M61.42M89.05M125.67M82.79M
Selling, General, and Administrative Expenses
26.56M41.58M49.34M60.06M30.11M
Operating Income
-69.34M-103.00M-138.39M-185.73M-112.90M
Interest Income/Expense
5.80M5.60M2.27M340.00K670.00K
Other Income/Expense
-24.00K727.00KN/AN/AN/A
Non Recurring Items
N/A-5.39MN/AN/AN/A
Income Before Taxes
-68.80M-102.06M-136.13M-185.39M-112.23M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-68.80M-102.06M-136.13M-185.39M-112.23M
EBITDA
-66.17M-99.28M-134.71M-184.19M-112.10M
 
Per Share Data
EPS Diluted Total Ops
-1.17-1.86-2.50-3.48-2.91
Non GAAP EPS
-1.17-1.86-2.50-3.48-3.08
 
Statistics

All data in USD

Charts